10-Q quarterly report · filed Nov 5, 2026

IBEX Ltd (IBEX) Q3 2026 10-Q Quarterly Report

Short answer

IBEX Ltd (IBEX) filed its Q3 2026 10-Q quarterly report on Nov 5, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $175M (up 15.9% year over year) with net income of $15M.

Q3 2026 key financials · XBRL

Revenue
$175M
+15.9% YoY
Net income
$15M
+22.7% YoY
Operating margin
10.4%
EPS (diluted)
$0.99
+20.7% YoY

Source: XBRL data from the IBEX Ltd (IBEX) Q3 2026 10-Q on SEC EDGAR. USD.

IBEX Ltd Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $175.2M, up 15.9% YoY from $151.2M, led by HealthTech growth of $8.7M, or 39.9%
  • Operating margin 10.4% vs 9.1% YoY, net income margin 8.4% vs 8.0%, adjusted EBITDA margin 14.4% vs 12.9%
  • Worst-performing vertical: FinTech revenue down $0.3M, or 1.7% YoY
  • Operating cash flow $16.3M vs $15.7M, capital expenditures $7.2M, free cash flow $9.2M vs $8.0M
  • Emerging headwinds: wage pressure, inflation, labor shortages, client shifts toward lower-priced offshore delivery, evolving AI regulation and adoption

Risk Factors

  • No material changes to Annual Report risk factors
  • Carried-forward financial risk: adverse effects on financial position, results, or cash flows
  • Unknown or currently immaterial risks could materially harm operations

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other IBEX Ltd quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.